Product Image

Contributor Information

  • Name Alessandra Cambi
  • Institute Radboud University Medical Center

Tool Details

  • Tool name: CD6-LifeAct-GFP Jurkat cell line cell line
  • Alternate names: CD6
  • Tool type: Cell Lines
  • Tool sub-type: Continuous
  • Parental cell line: Jurkat E6.1
  • Organism: Human
  • Tissue: Blood
  • Cancer type: Blood cancer
  • Disease: Cancer
  • Conditional: No
  • Description: Activation of the T cell receptor (TCR) on the T cell through ligation with antigen-MHC complex of an antigen-presenting cell (APC) is an essential process in the activation of T cells and induction of the subsequent adaptive immune response. Upon activation, the TCR, together with its associated co-receptor CD3 complex, assembles in signaling microclusters that are transported to the center of the organizational structure at the T cell-APC interface termed the immunological synapse (IS). During IS formation, local cell surface receptors and associated intracellular molecules are reorganized, ultimately creating the typical bull's eye-shaped pattern of the IS. CD6 is a surface glycoprotein receptor, which has been previously shown to associate with CD3 and co-localize to the center of the IS in static conditions or stable T cell-APC contacts.
  • Research area: Cancer; Cell biology; Cell signaling and signal transduction; Immunology
  • Production details: Jurkat cell lines stably expressing CD6-LifeAct-YFP were obtained by electroporation using the Neon Transfection System for Electroporation (Invitrogen) according to the manufacturer's guidelines. Shortly, 5*105 Jurkat cells were transfected at 1325 Volt (10 ms, 3 pulses) with 3 ÎĚ?Ÿg of DNA in 100 ÎĚ?Ÿl Resuspension buffer. After transfection cells were seeded in 2 ml of 1640 RPMI with 10% FCS and 1% U-glut. Antibiotics were added after 3 h. Stable cell lines were sorted on YFP expression on a FACSAria cell sorter (BD Biosciences), and cells were maintained in complete RPMI medium as described above, additionally supplemented with 500 ng/ml geneticin (G418, Gibco).

  • For Research Use Only

Target Details

  • Target: Cluster of Differentiation 6 labelled with RFP, CD6-RFP

Application Details


  • Format: Frozen
  • Growth medium: 1640 RPMI supplemented with 10% Fetal Calf Serum, 1 mM Ultra-glutamine and antibiotics (100 U/ml penicillin, 100?„?žg/ml streptomycin and 0.25 ?g/ml amphotericin B). 500 ng/ml geneticin.
  • Shipping conditions: Dry ice



  •   Meddens et al. 2018. Front Immunol. 9:2333. PMID: 30356797.